Bengaluru-based healthtech and diagnostics startup Orange Health Labs has raised Rs 277 Cr (~$30M) in a Series C funding round led by Iron Pillar India, as publicly reported on 22 June 2026. The capital infusion arrives roughly 18 months after the company’s previous raise and marks a significant step in its ambition to become a dominant at-home diagnostics platform across Indian metros.
Quick Highlights
- Founders: Tarun Bhambra and Dhruv Gupta
- Lead Investor: Iron Pillar India
- Participating Investors: Crescent Enterprises (Rs 37.7 Cr), Paramark Frontier Fund (Rs 37 Cr), Bertelsmann (Rs 21.8 Cr), Good Capital (Rs 15.5 Cr), Accel India (Rs 8 Cr), General Catalyst (Rs 1.8 Cr)
- Investor Background: Iron Pillar India is a growth-stage technology fund focused on Indian internet businesses
- Headquarters: Bengaluru, Karnataka
- Announcement Date: 22 June 2026
Funding Breakdown
Use of Funds
The Series C proceeds will be directed toward growth and expansion initiatives, with a primary focus on expanding Orange Health Labs’ physical footprint across multiple cities. The company intends to deepen its operational infrastructure to support higher order volumes as it scales beyond its current base.
Funding Timeline
This Series C round of Rs 277 Cr (~$30M) is the company’s most recently disclosed raise, closing approximately 18 months after its prior funding round. No further round-by-round history has been publicly confirmed in available disclosures.
Expansion Plans
Orange Health Labs is actively targeting geographic expansion into Mumbai, Delhi-NCR, and Hyderabad, building on the operational model it has established in Bengaluru. The company has set a clear financial milestone, aiming to achieve profitability at the company level by 2028.
Significance
Orange Health Labs’ Series C carries notable weight given the company’s reported momentum: it clocked Rs 180 Cr in annualised recurring revenue (ARR) in FY26, growing at a 65% compound annual growth rate, and has already achieved EBITDA profitability in its home market of Bengaluru. With over three million orders fulfilled to date, the round validates the at-home diagnostics model at scale in India. For the broader healthtech sector, this raise signals sustained investor confidence in asset-light, tech-enabled diagnostics platforms that prioritise unit economics alongside growth. The participation of marquee names including Accel India, Bertelsmann, and General Catalyst alongside the lead investor further reinforces the credibility of Orange Health Labs’ expansion thesis.
These details have been verified against multiple publicly available reports as of 22 June 2026.
Stay updated with the latest startup funding news on The Courtroom.
Disclaimer: This report is compiled from publicly available sources and is for informational purposes only; funding figures are as publicly reported and may be subject to change.
